Physician profile
Donald Feldman
NPI 1437240371
$1,851.72
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $362 · 2020: $125 · 2021: $103 · 2022: $413 · 2023: $709 · 2024: $140.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $849.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $849.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $374.89 | 2021-2023 | Iodosorb Ointment 40g USA, Collagenase Santyl, Allevyn Heel 10.5cm X 13.5cm Ctn 5 |
| Advanced Oxygen Therapy INC. | $255.40 | 2023-2024 | Topical Oxygen Chamber For Extremities, Topical Oxygen Chamber For Extremities |
| Next Science LLC | $144.94 | 2023 | Xperience, Blastx, Surgx |
| Polarityte, INC. | $141.84 | 2019 | |
| Nevro Corp. | $135.38 | 2022 | |
| Kerecis Limited | $127.87 | 2022 | |
| Organogenesis INC. | $124.99 | 2020 | |
| Paratek Pharmaceuticals, INC. | $124.98 | 2023 | Nuzyra |
| Cardiovascular Systems INC. | $116.67 | 2019 | |
| Medtronic, INC. | $110.00 | 2023 | Intellis Adaptivestim |
| Tactile Systems Technology INC | $103.64 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $91.12 | 2023 | Seglentis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donald Feldman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.